CN103384826B - 一种测定抗RA33抗体IgG的方法及试剂装置 - Google Patents
一种测定抗RA33抗体IgG的方法及试剂装置 Download PDFInfo
- Publication number
- CN103384826B CN103384826B CN201180063617.2A CN201180063617A CN103384826B CN 103384826 B CN103384826 B CN 103384826B CN 201180063617 A CN201180063617 A CN 201180063617A CN 103384826 B CN103384826 B CN 103384826B
- Authority
- CN
- China
- Prior art keywords
- reagent
- hole
- sample
- instrument
- navirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 186
- 238000000034 method Methods 0.000 title claims abstract description 55
- 238000012360 testing method Methods 0.000 claims abstract description 43
- 238000002965 ELISA Methods 0.000 claims abstract description 18
- 239000011159 matrix material Substances 0.000 claims abstract description 16
- 238000001514 detection method Methods 0.000 claims description 78
- 239000000523 sample Substances 0.000 claims description 69
- 238000007789 sealing Methods 0.000 claims description 23
- 238000004458 analytical method Methods 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 239000012895 dilution Substances 0.000 claims description 21
- 238000010790 dilution Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 19
- 238000003908 quality control method Methods 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 16
- 102000036639 antigens Human genes 0.000 claims description 16
- 108091007433 antigens Proteins 0.000 claims description 16
- 239000003547 immunosorbent Substances 0.000 claims description 16
- 238000011049 filling Methods 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 10
- 238000001467 acupuncture Methods 0.000 claims description 9
- 238000007689 inspection Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 8
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 6
- 239000012898 sample dilution Substances 0.000 claims description 6
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 6
- 229940033663 thimerosal Drugs 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000002372 labelling Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- 238000004164 analytical calibration Methods 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000003593 chromogenic compound Substances 0.000 claims description 3
- 238000012937 correction Methods 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 230000026676 system process Effects 0.000 claims description 3
- 239000013026 undiluted sample Substances 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims description 2
- 239000012490 blank solution Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000002932 luster Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000035699 permeability Effects 0.000 claims description 2
- 230000000007 visual effect Effects 0.000 claims description 2
- -1 position Substances 0.000 claims 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 18
- 230000000875 corresponding effect Effects 0.000 description 14
- 208000003250 Mixed connective tissue disease Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000013399 early diagnosis Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 108091026838 U1 spliceosomal RNA Proteins 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 1
- 108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000019040 Nuclear Antigens Human genes 0.000 description 1
- 108010051791 Nuclear Antigens Proteins 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000018359 Systemic autoimmune disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 108700020942 nucleic acid binding protein Proteins 0.000 description 1
- 102000044158 nucleic acid binding protein Human genes 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/52—Containers specially adapted for storing or dispensing a reagent
- B01L3/527—Containers specially adapted for storing or dispensing a reagent for a plurality of reagents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/54—Labware with identification means
- B01L3/545—Labware with identification means for laboratory containers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2011/070028 WO2012092708A1 (zh) | 2011-01-04 | 2011-01-04 | 一种测定抗ra33抗体igg的方法及试剂装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103384826A CN103384826A (zh) | 2013-11-06 |
CN103384826B true CN103384826B (zh) | 2015-11-25 |
Family
ID=46457180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180063617.2A Active CN103384826B (zh) | 2011-01-04 | 2011-01-04 | 一种测定抗RA33抗体IgG的方法及试剂装置 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130316381A1 (zh) |
CN (1) | CN103384826B (zh) |
DE (1) | DE112011104669T5 (zh) |
WO (1) | WO2012092708A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106404757A (zh) * | 2016-06-30 | 2017-02-15 | 深圳市亚辉龙生物科技股份有限公司 | 一种抗RA33抗体IgG化学发光免疫检测试剂盒及其制备方法 |
CN110514648A (zh) * | 2018-05-21 | 2019-11-29 | 博阳生物科技(上海)有限公司 | 一种化学发光分析poct检测装置及其应用 |
CN109030818A (zh) * | 2018-07-26 | 2018-12-18 | 上海微银生物技术有限公司 | 一种酶免疫检测板及其检测方法 |
CN109669041A (zh) * | 2019-02-02 | 2019-04-23 | 上海微银生物技术有限公司 | 一种酶免疫检测板条、酶免疫检测板及其检测方法 |
CN112730859B (zh) * | 2019-10-28 | 2024-07-26 | 东方伊诺(苏州)医疗科技有限公司 | 一种自动酶联免疫分析仪 |
CN111289759B (zh) * | 2020-03-10 | 2023-10-27 | 苏州翊讯生物科技有限公司 | Saa检测试剂盒及saa定量检测的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2554176Y (zh) * | 2002-07-01 | 2003-06-04 | 西安联尔生物技术有限公司 | 一种对风湿性疾病指标进行检测的生物芯片 |
CN1437707A (zh) * | 2000-04-28 | 2003-08-20 | 三菱化学株式会社 | 自动检测检测盒及利用它进行检测的方法 |
CN201611346U (zh) * | 2009-09-17 | 2010-10-20 | 深圳市亚辉龙生物科技有限公司 | 一种用于酶联免疫检测的分析装置 |
CN201689095U (zh) * | 2010-01-04 | 2010-12-29 | 深圳市亚辉龙生物科技有限公司 | 一种全自动自身抗体分析仪 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879508A (en) | 1986-04-04 | 1989-11-07 | Mitutoyo Corporation | Capacitance-type measuring device for absolute measurement of positions |
ATE140538T1 (de) * | 1992-03-05 | 1996-08-15 | Univ Dublin | Vorrichtung zum antigennachweis |
-
2011
- 2011-01-04 DE DE112011104669T patent/DE112011104669T5/de not_active Ceased
- 2011-01-04 CN CN201180063617.2A patent/CN103384826B/zh active Active
- 2011-01-04 WO PCT/CN2011/070028 patent/WO2012092708A1/zh active Application Filing
- 2011-01-04 US US13/978,233 patent/US20130316381A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437707A (zh) * | 2000-04-28 | 2003-08-20 | 三菱化学株式会社 | 自动检测检测盒及利用它进行检测的方法 |
CN2554176Y (zh) * | 2002-07-01 | 2003-06-04 | 西安联尔生物技术有限公司 | 一种对风湿性疾病指标进行检测的生物芯片 |
CN201611346U (zh) * | 2009-09-17 | 2010-10-20 | 深圳市亚辉龙生物科技有限公司 | 一种用于酶联免疫检测的分析装置 |
CN201689095U (zh) * | 2010-01-04 | 2010-12-29 | 深圳市亚辉龙生物科技有限公司 | 一种全自动自身抗体分析仪 |
Non-Patent Citations (3)
Title |
---|
抗CCP、RA33抗体的检测在早期类风湿关节炎诊断中的应用;程艳杰等;《医师进修杂志》;20050331;第28卷(第3期);22-24 * |
抗CCP、抗RA33等4种自身抗体在类风湿关节炎诊断中的应用;崔天盆等;《上海医学检验杂志》;20031231;第18卷(第4期);221-222 * |
抗角蛋白抗体、抗RA33抗体及类风湿因子在老年起病得类风湿关节炎中的意义;李博等;《广东医学》;20071031;第28卷(第10期);1644-1646 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012092708A1 (zh) | 2012-07-12 |
CN103384826A (zh) | 2013-11-06 |
US20130316381A1 (en) | 2013-11-28 |
DE112011104669T5 (de) | 2013-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102147409B (zh) | 一种测定抗核小体抗体IgG的方法及试剂装置 | |
CN102147408A (zh) | 一种测定抗SmD1抗体IgG的方法及试剂装置 | |
CN103384826B (zh) | 一种测定抗RA33抗体IgG的方法及试剂装置 | |
CN102147412A (zh) | 一种测定抗蛋白酶3抗体IgG的方法及试剂装置 | |
CN103185793B (zh) | 一种检测幽门螺杆菌抗体的试剂装置及其方法 | |
CN103185797B (zh) | 一种检测抗髓过氧化物酶抗体的试剂装置及其方法 | |
CN102156190A (zh) | 一种测定抗β2糖蛋白I抗体IgG/A/M的方法及试剂装置 | |
CN201955337U (zh) | 一种测定抗心磷脂抗体IgG的试剂装置 | |
CN103185800B (zh) | 一种检测抗环瓜氨酸多肽抗体的试剂装置及其方法 | |
CN103185801B (zh) | 一种检测抗β2糖蛋白I抗体的试剂装置及其方法 | |
CN103185788B (zh) | 一种检测类风湿因子的方法 | |
CN103185785B (zh) | 一种检测抗心磷脂抗体的试剂装置及其方法 | |
CN103185779B (zh) | 一种检测抗核抗体的试剂装置及其方法 | |
CN201993361U (zh) | 一种测定抗心磷脂抗体IgM的试剂装置 | |
CN101963618B (zh) | 在抗体微阵列系统中识别异嗜性抗体干扰的方法及应用其检测目标抗原的抗体微阵列芯片 | |
CN103185777B (zh) | 一种检测抗Jo-1抗体的试剂装置及其方法 | |
CN103185784B (zh) | 一种检测肺炎支原体抗体的试剂装置及其方法 | |
CN103185787B (zh) | 一种检测抗ssa抗体的方法 | |
CN103185795B (zh) | 一种检测eb病毒抗体的试剂装置及其方法 | |
CN103185786B (zh) | 一种检测抗双链dna抗体的试剂装置及其方法 | |
CN103185778B (zh) | 一种检测抗Scl70抗体的试剂装置及其方法 | |
CN103185780B (zh) | 一种检测抗U1-snRNP抗体的试剂装置及其方法 | |
CN103185782A (zh) | 一种检测抗线粒体抗体m2型的试剂装置及其方法 | |
CN103185781B (zh) | 一种检测抗肾小球基底膜抗体的试剂装置及其方法 | |
CN103185792B (zh) | 一种检测腮腺炎病毒抗体的试剂装置及其方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Nanshan District Nanshan street Shenzhen city Guangdong province 518000 Xing Hai Lu Lai Shan Industrial Zone 5 1-4 Patentee after: SHENZHEN YHLO BIOTECH CO., LTD. Address before: 518054, Lai Shan Industrial Zone, Nanshan Road, Shenzhen, Guangdong, Fifth Patentee before: Shenzhen Yhlo Biotech. Co., Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 518000 Shenzhen 1 Longgang biological technology plant 1, Baolong two road, Baolong street, Guangdong Patentee after: SHENZHEN YHLO BIOTECH CO., LTD. Address before: 518000 Guangdong, Shenzhen, Nanshan District Nanshan street, Xinghai Road, Li Shan Industrial Zone, 1-4 1-4 floors. Patentee before: SHENZHEN YHLO BIOTECH CO., LTD. |
|
CP02 | Change in the address of a patent holder |